5% Dextrose Injection, USP, 50 mL ADD-Vantage Unit, Rx only, Distributed by Hospira, INC., Lake Forest, IL 60045 USA, NDC 0409-7100-68/0409-7100-66
Published December 8, 2021 · Recall initiated: November 30, 2021
Summary
FDA records drug Class II recall D-0265-2022, published December 8, 2021 and initiated November 30, 2021. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 765 bags; Lot: Lot: 4923608 Exp. 1MAY2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of sterility assurance: bag has the potential to leak.
What to do
Voluntary: Firm initiated · Letter
Get an email if DEXTROSE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DEXTROSE
- Manufacturer
- Pfizer Inc.
- Distributor
- USA Nationwide
- Lot
- Lot: 4923608 Exp. 1MAY2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524,April 29, 2026
- FDA5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, Fresenius KabiApril 15, 2026
- FDA5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius Kabi USA,April 15, 2026
- FDA5% Dextrose Injection, USP 5 g per 100 mL (50 mg per mL) 100 mL in a 100 mL freeflex bag, Fresenius Kabi USA,April 15, 2026
- FDATydemy (drospirenone, ethinyl estradiol & levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolateDecember 8, 2021
- FDAEnoxaparin Sodium Injection, USP, 40 mg/0.4 mL, Single-Dose Syringes with Automatic Safety Device, ForDecember 8, 2021
Questions about this recall
Was 5% Dextrose Injection, USP, 50 mL ADD-Vantage Unit, Rx only, Distributed by Hospira, INC., Lake Forest, IL 60045 USA, NDC 0409-7100-68/0409-7100-66 recalled?
Yes. FDA published recall D-0265-2022 on December 8, 2021. Reported hazard: Lack of sterility assurance: bag has the potential to leak.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DEXTROSE.